In the studies reviewed herein, psilocybin increased SV2A under basal conditions in pigs (58), whereas ketamine increased SV2A only among humans with depression/PTSD who had low baseline SV2A expression in the hippocampus and PFC (78). This evidence concerns the gene SV2A and post-traumatic stress disorder.